NCT00272246

Brief Summary

Primary generalized dystonia, also called idiopathic torsion dystonia or dystonia musculorum deformans is a disabling neurological condition which usually starts in childhood, mostly in a lower limb and spreads to other body parts as the disease progresses. Medical treatment is usually ineffective and most patients become wheelchair bound or even bedridden. Recently several case series and one RCT reported favourable results of bilateral deep brain stimulation (DBS) of the globus pallidus internus (GPi) for primary generalized dystonias. However, the number of patients treated with bilateral GPi stimulation is still limited. Therefore, we propose a RCT to investigate whether bilateral DBS of the GPi is an effective and safe treatment in patients with primary generalized dystonia.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
24

participants targeted

Target at below P25 for phase_2

Timeline
Completed

Started Feb 2005

Typical duration for phase_2

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2005

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

January 4, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 5, 2006

Completed
1.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2007

Completed
Last Updated

January 5, 2006

Status Verified

January 1, 2006

First QC Date

January 4, 2006

Last Update Submit

January 4, 2006

Conditions

Keywords

dystonia

Outcome Measures

Primary Outcomes (1)

  • change in BFMDRS-motor score from baseline to six months after stimulation equipment implantation

Secondary Outcomes (6)

  • BFMDRS-disability score

  • MOS-SF-36 (Medical Outcome Scale)

  • GOS (Global Outcome Scale)

  • Neuropsychological and neuropsychiatric validated scales

  • Questionnaire designed for the registration of the number and extent of morbidity due to the surgical

  • +1 more secondary outcomes

Interventions

Eligibility Criteria

Age12 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Invalidating primary generalized dystonia (BFMDRS-motor part \>= 35)
  • Disease duration \>= 5 yrs
  • Age at surgery between 12 and 60
  • Insufficient improvement with pharmacological and physical therapy
  • Signed informed consent, for patients \< 19 yrs of age a written consent of the parent(s) or caretaker(s) is needed.

You may not qualify if:

  • Mental retardation or dementia (MMSE \<24)
  • Depressive state (HADS\>21)
  • History of former stereotactic brain surgery
  • Severe brain atrophy
  • General surgical contraindications, such as uncontrolled hypertension or diabetes mellitus, cardiovascular or pulmonary risks, disturbances of bloodclotting.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Neurology, Movement Disorders Center

Amsterdam, 1100 DD, Netherlands

RECRUITING

Related Publications (1)

  • Foncke EM, Speelman JD. [Primary generalized dystonia and deep brain stimulation: a randomized, placebo-controlled, double-blind, multicentre study]. Ned Tijdschr Geneeskd. 2005 May 14;149(20):1123-4. Dutch.

    PMID: 15932141BACKGROUND

MeSH Terms

Conditions

Dystonia

Condition Hierarchy (Ancestors)

DyskinesiasNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Hans Speelman, PhD

    Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    STUDY CHAIR

Central Study Contacts

Elisabeth MJ Foncke, MD

CONTACT

Hans Speelman, MD,PhD

CONTACT

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

January 4, 2006

First Posted

January 5, 2006

Study Start

February 1, 2005

Study Completion

December 1, 2007

Last Updated

January 5, 2006

Record last verified: 2006-01

Locations